FDA and EUA regulatory approvals, rising investment, and policy backing from governments worldwide point to a promising future for the biotech industry. Further, the sector could also benefit from an aging population and the increasing preference for online and remote diagnosis and treatment of patients worldwide.
With rising chronic diseases and growing investments in research and development, the biotech industry is poised to grow considerably this year and beyond. The global biotechnology market is projected to reach $1040.1 billion by 2030, growing at a 7.5% CAGR.
